Stock research
BIAFW bioAffinity Technologies, Inc.
Healthcare • Medical - Specialties
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United...…
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
5Y change
-95.52%
Range high
$2.10
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in BIAFW?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.09
- Day High
- $0.47
- Day Low
- $0.09
- 52w High
- $0.47
- 52w Low
- $0.09
- Volume
- 1,000
- Avg Volume
- Beta
- -1.11
* TTM/most recent where available
Company
- Ticker
- BIAFW
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- US
- CEO
- Maria Zannes
- Employees
- 57
- Website
- www.bioaffinitytech.com
Key Metrics
- Market Cap
- 2.84M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).